Business Description
Kineta Inc
NAICS : 325412
SIC : 2834
ISIN : US49461C1027
Description
Kineta Inc is a clinical-stage biotechnology company with a mission to develop next generation immunotherapies that transform patients' lives. The company's asset is KVA12.1, a VISTA blocking immunotherapy.
Financial Strength
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 1.27 | |||||
| Equity-to-Asset | -5.82 | |||||
| Debt-to-Equity | -0.09 | |||||
| Debt-to-EBITDA | -0.04 | |||||
| Piotroski F-Score | 3/9 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | -39.1 | |||||
| 3-Year EBITDA Growth Rate | -44.1 | |||||
| 3-Year EPS without NRI Growth Rate | 5.7 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 33.1 | |||||
| 9-Day RSI | 26.77 | |||||
| 14-Day RSI | 28.49 | |||||
| 6-1 Month Momentum % | 45.74 | |||||
| 12-1 Month Momentum % | -80.05 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 0.14 | |||||
| Quick Ratio | 0.14 | |||||
| Cash Ratio | 0.1 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -29.3 | |||||
| Shareholder Yield % | 52.78 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| FCF Margin % | -175.27 | |||||
| ROA % | -246.64 | |||||
| ROIC % | -388.22 | |||||
| ROC (Joel Greenblatt) % | -4321.5 | |||||
| ROCE % | -28335.18 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 0.75 | |||||
| EV-to-EBIT | -0.19 | |||||
| EV-to-Forward-EBIT | -0.52 | |||||
| EV-to-EBITDA | -0.19 | |||||
| EV-to-Revenue | 0.71 | |||||
| EV-to-Forward-Revenue | 1.21 | |||||
| EV-to-FCF | -0.49 | |||||
| Earnings Yield (Greenblatt) % | -526.32 | |||||
| FCF Yield % | -213.09 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with OTCPK:KANT
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Kineta Inc Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 5.442 | ||
| EPS (TTM) ($) | -1.74 | ||
| Beta | 0 | ||
| Volatility % | 91.79 | ||
| 14-Day RSI | 28.49 | ||
| 14-Day ATR ($) | 0.062275 | ||
| 20-Day SMA ($) | 0.552208 | ||
| 12-1 Month Momentum % | -80.05 | ||
| 52-Week Range ($) | 0.26 - 4.77 | ||
| Shares Outstanding (Mil) | 12.26 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 3 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Kineta Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Kineta Inc Stock Events
| Event | Date | Price($) | ||
|---|---|---|---|---|
| No Event Data | ||||
Kineta Inc Frequently Asked Questions
What is Kineta Inc(KANT)'s stock price today?
The current price of KANT is $0.37. The 52 week high of KANT is $4.77 and 52 week low is $0.26.
When is next earnings date of Kineta Inc(KANT)?
The next earnings date of Kineta Inc(KANT) is 2025-02-21 Est..
Does Kineta Inc(KANT) pay dividends? If so, how much?
Kineta Inc(KANT) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers